Abstract P4-08-13: The Use of Reverse Phase Protein Arrays (RPPA), Principal Component Analysis (PCA), and CScape Pathway Mapping to Identify New Tumor Vulnerability and Actionable Targets in Human Malignant Triple-Negative Breast cancer cell lines

MLA

Andrew P. Howell, et al. “Abstract P4-08-13: The Use of Reverse Phase Protein Arrays (RPPA), Principal Component Analysis (PCA), and CScape Pathway Mapping to Identify New Tumor Vulnerability and Actionable Targets in Human Malignant Triple-Negative Breast Cancer Cell Lines.” Cancer Research, vol. 83, Mar. 2023, pp. P4-08. EBSCOhost, https://doi.org/10.1158/1538-7445.sabcs22-p4-08-13.

APA

Andrew P. Howell, Julia Wulfkuhle, Rosa I. Gallagher, Emanuel F. Petricoin, & Amy H. Tang. (2023). Abstract P4-08-13: The Use of Reverse Phase Protein Arrays (RPPA), Principal Component Analysis (PCA), and CScape Pathway Mapping to Identify New Tumor Vulnerability and Actionable Targets in Human Malignant Triple-Negative Breast cancer cell lines. Cancer Research, 83, P4-08. https://doi.org/10.1158/1538-7445.sabcs22-p4-08-13

Chicago

Andrew P. Howell, Julia Wulfkuhle, Rosa I. Gallagher, Emanuel F. Petricoin, and Amy H. Tang. 2023. “Abstract P4-08-13: The Use of Reverse Phase Protein Arrays (RPPA), Principal Component Analysis (PCA), and CScape Pathway Mapping to Identify New Tumor Vulnerability and Actionable Targets in Human Malignant Triple-Negative Breast Cancer Cell Lines.” Cancer Research 83 (March): P4-08. doi:10.1158/1538-7445.sabcs22-p4-08-13.